**Flu activity remains at seasonal lows in late summer 2026, driving strong trader consensus toward a hospitalization rate of 0.1 per 100,000 population for Week 33 (mid-to-late August).** CDC surveillance through RESP-NET, FluSurv-NET, and NHSN shows influenza-associated hospitalization rates near or at zero outside the typical October–May season, with Week 28 data reporting 0.0 per 100,000 (FluSurv-NET) and 0.2 per 100,000 (NHSN nationally). This pattern aligns with established epidemiology: warmer temperatures, higher humidity, reduced indoor crowding, and lower viral stability suppress transmission, producing the observed near-baseline levels. Recent CDC updates as of August 28 confirm overall acute respiratory illness activity is very low, with no summer flu surge or anomalous detections. Market-implied odds reflect this evidence-based expectation of minimal burden, tempered by minor uncertainty around exact reporting thresholds, rounding in surveillance systems, and potential small upticks from sporadic cases. Upcoming weekly RESP-NET and FluView releases will provide the final confirmation for resolution.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedFlu Hospitalization Rate Week 33, 2026?
0.1 100.0%
<0.1 <1%
>0.1 <1%
$931 Vol.
$931 Vol.
<0.1
No
0.1
Yes
>0.1
No
0.1 100.0%
<0.1 <1%
>0.1 <1%
$931 Vol.
$931 Vol.
<0.1
No
0.1
Yes
>0.1
No
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Market Opened: Aug 21, 2026, 11:58 AM ET
Resolver
0x69c47De9D...Outcome proposed: Yes
No dispute
Final outcome: Yes
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Resolver
0x69c47De9D...Outcome proposed: Yes
No dispute
Final outcome: Yes
**Flu activity remains at seasonal lows in late summer 2026, driving strong trader consensus toward a hospitalization rate of 0.1 per 100,000 population for Week 33 (mid-to-late August).** CDC surveillance through RESP-NET, FluSurv-NET, and NHSN shows influenza-associated hospitalization rates near or at zero outside the typical October–May season, with Week 28 data reporting 0.0 per 100,000 (FluSurv-NET) and 0.2 per 100,000 (NHSN nationally). This pattern aligns with established epidemiology: warmer temperatures, higher humidity, reduced indoor crowding, and lower viral stability suppress transmission, producing the observed near-baseline levels. Recent CDC updates as of August 28 confirm overall acute respiratory illness activity is very low, with no summer flu surge or anomalous detections. Market-implied odds reflect this evidence-based expectation of minimal burden, tempered by minor uncertainty around exact reporting thresholds, rounding in surveillance systems, and potential small upticks from sporadic cases. Upcoming weekly RESP-NET and FluView releases will provide the final confirmation for resolution.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated


Beware of external links.
Beware of external links.
Frequently Asked Questions